BD Pharmingen™ Purified NA/LE Anti-Human CD49d Natalizumab Biosimilar

Alternative Name: CD49D; CD49d; CD49dCD29; ITGA4; Integrin alpha 4; Integrin α4β1; Integrin α4β7; Itga4; VLA-4; VLA-4 alpha; integrin alpha-4
Reactivity: Human (QC Testing)
Isotype: Human IgG4, κ
Immunogen: Human α4β1 Integrin
Application: Flow cytometry (Routinely Tested), Blocking (Tested During Development)
Concentration: 1.0 mg/ml
Entrez Gene ID: 3676
Storage Buffer: No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2 µm sterile filtered. Endotoxin level is ≤0.01 EU/µg (≤0.001 ng/µg) of protein as determined by the LAL assay.
Regulatory Status: RUO
Preparation And Storage: Preparation And Storage The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. This preparation contains no preservatives, thus it should be handled under aseptic conditions. Store undiluted at 4°C.
Product Notices: Product Notices Please refer to www.bdbiosciences.com/us/s/resources for technical protocols. Since applications vary, each investigator should titrate the reagent to obtain optimal results. Please refer to http://regdocs.bd.com to access safety data sheets (SDS). For U.S. patents that may apply, see bd.com/patents.